Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...

Sarah Bochenick, a health insurance specialist in Harford County, was watching TV with her husband a year ago when she ...

Late-Breaking Science Abstract LB 032 - In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting ...

Understanding seizure causes and their warning signs together with when to seek medical help is crucial because not all ...

An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health ...

Physical rehabilitation and symptom management still remain the mainstay of treatment for stroke, as clot removal or ...

Harford County woman Sarah Bochenick's stroke recovery story highlights how quick medical response can save lives and prevent ...

Researchers studying nearly 2 million older adults found that cerebral amyloid angiopathy sharply raises the risk of ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

American Stroke Association International Stroke Conference 2026 annual awards go to 11 stroke researchers for science, brain health contributions.

A hidden protein buildup in brain blood vessels may quietly quadruple dementia risk—often without a stroke as warning.